Quo Vadis Aortic Surgery ?

Prof. Schmidli introduces Prof. Senning's pioneering cardiac work, discusses mortality rates in AAA, Bern's OAR experience, aortic arch procedures, graft infections, and future innovations, emphasizing training and simulation for future surgeons.

Aktuelle Entwicklungen im Bereich der langfristigen mechanischen Kreislaufunterstutzung… und ein Albtraum

Current developments in the field of long-term mechanical cycle support... and a nightmare.

Residency Program in Austria

Dr Pölzl explains how the residency curriculum works in Austria.

SAVR vs TAVI in low risk patients

Dr. Muretti compares TAVI and SAVR, discussing EVOLUT LOW RISK, PARTNER 3, SURTAVI, and NOTION trials, highlighting outcomes like mortality, regurgitation, safety, and recovery.

SGHC at Summer School Bern

Prof. Huber presents the Swiss Society of Cardiac Surgery during the Summer School in Bern.

Rôle de la revascularisation - quel bénéfice et pour quels patients ?

Prof. Roffi presents on 3 aspects of revascularisation: impact on angina, impact on outcomes, impact on heart failure.

Aktuelle Entwicklungen im Bereich der langfristigen mechanischen Kreislaufunterstutzung… und ein Albtraum

Evolution du traitement antiplaquettaire et anticoagulant post angioplastie coronarienne dans la maladie coronarienne stable

Evolution du traitement antiplaquettaire et anticoagulant post angioplastie coronarienne dans la maladie coronarienne stable

Prof. Iglesias presents on the topic of progression of antiplatelet and anticoagulant therapy after coronary angioplasty in stable coronary artery disease.